Skip to main content
. 2021 Jul 21;12(1):4123–4135. doi: 10.1080/21655979.2021.1953215

Figure 7.

Figure 7.

The different sensitivity of high- and low-risk groups to chemotherapeutics drugs. (a–d) The low-risk group was associated with a higher half inhibitory concentration (IC50) in Docetaxel, Gefitinib, Paclitaxel, Rapamycin, Gemcitabine, and Cisplatin